Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women
Completed
Pfizer
Phase 4
2005-03-01
The purpose of the study is to assess the impact of treatment with tolterodine ER versus
placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms.
Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women
Completed
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 4
2005-03-01
The purpose of the study is to assess the impact of treatment with tolterodine ER versus
placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms.
Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction
Completed
Pfizer
Phase 4
2004-11-01
The primary objective of the trial is to evaluate the effect of tolterodine ER plus
tamsulosin versus placebo on patient perception of overall treatment benefit in men who have
frequency and urgency, with or without urinary urge incontinence (UUI), with or without
bladder outlet obstruction (BOO).
Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction
Completed
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 4
2004-11-01
The primary objective of the trial is to evaluate the effect of tolterodine ER plus
tamsulosin versus placebo on patient perception of overall treatment benefit in men who have
frequency and urgency, with or without urinary urge incontinence (UUI), with or without
bladder outlet obstruction (BOO).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
